What are the peri‑operative implications of administering magnesium during anesthesia, including its effects on anesthetic and opioid requirements, analgesia, neuromuscular blockade, potential adverse effects, recommended dosing, monitoring, and contraindications?

Magnesium Anaesthesia Implications

Perioperative magnesium sulfate is an effective opioid-sparing adjunct that reduces anesthetic requirements, enhances postoperative analgesia, and potentiates neuromuscular blockade, with a favorable safety profile when dosed appropriately.

Mechanism of Action

Magnesium acts through multiple pathways that make it valuable in anesthesia 1:

• NMDA receptor antagonism - blocks central sensitization and wind-up phenomenon
• Calcium channel blockade - reduces catecholamine release and provides vasodilation
• Inhibition of acetylcholine release at the neuromuscular junction
• Anti-inflammatory and anti-nociceptive effects 2

These mechanisms align with current guideline recommendations for multimodal analgesia 3, 4.

Effects on Anesthetic Requirements

Induction and Maintenance Agents

Magnesium significantly reduces propofol requirements 5:

• Induction: 28.52 mg reduction (p<0.001)
• Maintenance: 213.56 mg reduction (p<0.001)

The total intravenous anesthesia requirements decrease while maintaining adequate depth under BIS monitoring 6.

Opioid-Sparing Effects

Magnesium substantially reduces perioperative opioid consumption 7, 8:

• Intraoperative fentanyl reduced by 53.57 mcg (p<0.001) 5
• Postoperative morphine consumption significantly decreased at 24-48 hours 6
• Pain scores reduced at both early (within 6 hours) and late (up to 24 hours) timepoints 7

This fits within the framework of opioid-free or opioid-sparing anesthesia endorsed by recent guidelines 3.

Neuromuscular Blockade

Critical consideration: Magnesium potentiates non-depolarizing neuromuscular blocking agents 5, 6:

• Reduces rocuronium requirements by approximately 2.99 mg (p<0.001) 5
• Mean rocuronium consumption decreased from 0.44 to 0.35 mcg/kg/min 6
• Risk of residual neuromuscular blockade reported in 39.46% of cases 9

Pitfall to avoid: Reduce neuromuscular blocker doses by 20-30% when using magnesium and ensure rigorous neuromuscular monitoring with train-of-four assessment before extubation.

Recommended Dosing Protocol

Based on the most common effective regimen 9, 6:

Loading dose: 30-50 mg/kg IV bolus before induction (administered over 10-15 minutes)

Maintenance infusion: 15 mg/kg/hour IV continuous infusion throughout surgery

This dosing provides therapeutic benefit while minimizing adverse effects.

Postoperative Benefits

Beyond intraoperative effects, magnesium improves recovery 7, 8:

• Reduced postoperative pain scores (MD -0.72; 95% CI -0.99, -0.44; p<0.00001)
• Decreased shivering incidence 6
• Longer time to first rescue analgesia 7
• Improved patient satisfaction 8
• Enhanced hemodynamic stability during intubation and emergence 6

Adverse Effects and Monitoring

Common Side Effects (in order of frequency) 9:

1. Hypotension (55.48%) - most frequent, particularly post-intubation and immediate postoperative period
2. Residual neuromuscular blockade (39.46%) - requires vigilant monitoring
3. Hypermagnesemia (8.90%) - rare at recommended doses
4. IV injection site pain (7.71%)

Monitoring Requirements

• Blood pressure: Expect 10-15% reduction; treat if symptomatic or MAP <65 mmHg
• Neuromuscular function: Mandatory train-of-four monitoring; ensure TOF ratio >0.9 before extubation
• Serum magnesium levels: Only if renal impairment present or prolonged infusions
• Respiratory function: No significant respiratory depression in patients with normal renal function 2

Contraindications

Absolute contraindications:

• Severe renal impairment (CrCl <30 mL/min)
• Myasthenia gravis or other neuromuscular disorders
• Heart block (2nd or 3rd degree AV block)

Relative contraindications:

• Moderate renal impairment (dose adjustment required)
• Pre-existing hypotension
• Concurrent use of calcium channel blockers (increased hypotension risk)

Clinical Application Algorithm

For elective surgery under general anesthesia:

1. Pre-induction: Administer magnesium sulfate 30-50 mg/kg IV over 10-15 minutes
2. Induction: Reduce propofol dose by 20-30%
3. Neuromuscular blockade: Reduce rocuronium/vecuronium dose by 25-30%
4. Maintenance: Continue magnesium 15 mg/kg/hour infusion
5. Opioid dosing: Reduce fentanyl/remifentanil by 30-40% initially, titrate to effect
6. Emergence: Ensure TOF ratio >0.9 before extubation; have sugammadex readily available
7. Postoperative: Incorporate into multimodal analgesia protocol 4

Evidence Quality Considerations

The 2024 meta-analysis of 31 studies with 1,762 participants provides the strongest recent evidence for magnesium's analgesic efficacy 7. The 2017 meta-analysis of 20 trials confirms anesthetic-sparing effects 5. Both demonstrate consistent benefits across multiple surgical specialties 8, 10.

The evidence strongly supports magnesium as part of multimodal analgesia, aligning with ASA guidelines recommending multimodal approaches and individualized dosing regimens 4. Recent 2023 guidelines specifically endorse perioperative magnesium for reducing postoperative pain and opioid consumption 3.

Key Clinical Pearls

• Magnesium is inexpensive, widely available, and easy to administer 2
• Effects are dose-dependent; stay within recommended ranges
• Greatest benefit seen in procedures with significant postoperative pain (orthopedic, abdominal, gynecologic) 7, 10
• No respiratory depression at therapeutic doses in patients with normal renal function 2
• Consider as first-line adjunct in opioid-tolerant patients 3